NEW YORK, Nov. 28 (GenomeWeb News) - The National Cancer Institute awarded a total of $10 million to six research groups developing molecular markers for cancer, the agency said today.
The projects will confirm, refine, and evaluate molecular signatures; develop reproducible assays for molecular signatures; and identify molecular markers to be used in clinical decisions.
The grants are part of NCI's Strategic Partnering to Evaluate Cancer Signatures program.
Six institutions received the grant: the Children's Hospital in Los Angeles, Calif., University of California in Irvine; the University of Nebraska Medical Center in Omaha; the University of New Mexico in Albuquerque; Vanderbilt-Ingram Cancer Center in Nashville, Tenn.; and Washington University's Department of Medicine in St. Louis.